Orthotopic administration of 213...

Immunotherapy 2012 / 05 Vol. 4; Iss. 5

Orthotopic administration of 213 Bi–bevacizumab inhibits progression of PC3 xenografts in the prostate

Rizvi, SMA, Allen, BJ, Lee, CS, Bruchertseifer, F, Apostolidis, C, Morgenstern, A, Clarke, RA
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Language:
english
Journal:
Immunotherapy
DOI:
10.2217/imt.12.42
Date:
May, 2012
File:
PDF, 594 KB
english, 2012
Conversion to is in progress
Conversion to is failed